Keratin variants associate with progression of fibrosis during chronic hepatitis C infection
Pavel Strnad, Tim C. Lienau, Guo‐Zhong Tao, Laura C. Lazzeroni, Felix Stickel, Detlef Schuppan, M. Bishr Omary – 25 May 2006 – Keratins 8 and 18 (K8/K18) protect the liver from various forms of injury. Studies of liver explants from a large cohort of U.S. patients showed that K8/K18 mutations confer a risk to developing end‐stage liver diseases, though which diseases are preferentially involved is unknown. We tested the hypothesis that K8/K18 variants are associated with chronic hepatitis C (CHC) and that their presence correlates with progression of fibrosis.